Cell And Developmental Biology
-
Vanderbilt basic scientists receive National Science Foundation grant to explore RNA behavior
Manuel Ascano and Alissa Weaver are one of nine research teams to receive funding to understand the potential biotechnological uses of RNA more fully. The research is expected to provide opportunities to partner with industry to translate knowledge gained in the laboratory into marketable new therapeutics. Read MoreMar. 18, 2024
-
DNA is the ultimate blueprint— but epigenetics changes how it’s read
William Tansey, professor of cell and developmental biology and biochemistry and co-leader of the Vanderbilt-Ingram Cancer Center Genome Maintenance Program, gives us a bird’s-eye view of epigenetics and some of Vanderbilt’s research contributions to the space. Read MoreMar. 7, 2024
-
Through the lens: Vanderbilt’s excellence in microscopy revealed in Nikon Small World awards
Dylan Burnette, associate professor of cell and developmental biology, and Olivia Perkins, a graduate student in the Department of Cell and Developmental Biology, were awarded prizes in the 2022 Nikon Small World and Nikon Small World in Motion competitions. Read MoreMar. 7, 2024
-
Spotlight: Barrier breakers
By putting one foot in front of another, these trailblazers have changed Vanderbilt—and the world—with their dedication to basic research and breaking down barriers for themselves and others. Read MoreMar. 7, 2024
-
Five Basic Sciences faculty named to Vanderbilt University 2024 endowed chair cohort
Bruce Carter, Lisa Monteggia, Richard O’Brien, Andrea Page-McCaw, and Kevin Schey have been named endowed chairs, the highest academic award that Vanderbilt can give to a faculty member. Read MoreMar. 1, 2024
-
Colorectal cancer ‘cartography’ reveals an avenue to improved immunotherapy
Second only to lung cancer, colorectal cancer is the nation’s leading cancer killer — accounting for more than 52,000 deaths in the United States each year. Colorectal cancers are divided into two main groups, based on microsatellites, or repeat sections, in their DNA. Read MoreDec. 11, 2023
-
Novel C. diff structures are required for infection, offer new therapeutic targets
A team of Vanderbilt researchers discovered that C. diff produces the spheres, called ferrosomes, and that these structures are important for infection in an animal model. The findings are a rare demonstration of a membrane-bound structure inside a pathogenic bacterium. Read MoreNov. 15, 2023
-
Ken Lau named 2023 Stanley Cohen Innovation Fund Awardee
Ken Lau, professor of cell and developmental biology, will receive a one-year research award from the Stanley Cohen Innovation Fund. This work will propel Vanderbilt forward as a leader in the field by leveraging novel technology to develop customized sequencing-based assays of cell-associated components at the single-cell resolution. Read MoreNov. 7, 2023
-
Godschalk Research Fund strengthens biomedical innovation
By Aaron Conley Kyle Riedmann Zenobia Godschalk and Mark Godschalk, BA’92, of Atlanta, Georgia, have established the Zenobia and Mark Godschalk Research Fund within the School of Medicine Basic Sciences to support novel research in biology or immunology. The inaugural award of the research fund has been presented to Kyle… Read MoreOct. 27, 2023
-
Richmond lab identifies a key regulator of melanoma development
By Kensey Bergdorf Ann Richmond In a continuation of previous work studying the role of chemokine receptor CXCR2 in immune cells published in Cancer Immunology Research, the lab of Ann Richmond, Ingram Professor of Cancer Biology and professor of pharmacology, has identified that same receptor as a regulator of melanoma… Read MoreJun. 15, 2023